JP2019182869A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019182869A5 JP2019182869A5 JP2019104161A JP2019104161A JP2019182869A5 JP 2019182869 A5 JP2019182869 A5 JP 2019182869A5 JP 2019104161 A JP2019104161 A JP 2019104161A JP 2019104161 A JP2019104161 A JP 2019104161A JP 2019182869 A5 JP2019182869 A5 JP 2019182869A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- pyrrolidin
- propan
- dioxin
- dihydrobenzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 nitro, cyano, amino Chemical group 0.000 claims 91
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 58
- 150000001875 compounds Chemical class 0.000 claims 32
- 239000000203 mixture Substances 0.000 claims 28
- 150000003839 salts Chemical class 0.000 claims 28
- 125000005843 halogen group Chemical group 0.000 claims 23
- 125000000217 alkyl group Chemical group 0.000 claims 19
- 125000001072 heteroaryl group Chemical group 0.000 claims 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 18
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 14
- 125000001188 haloalkyl group Chemical group 0.000 claims 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims 10
- 125000003282 alkyl amino group Chemical group 0.000 claims 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 125000004438 haloalkoxy group Chemical group 0.000 claims 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 5
- 229930186217 Glycolipid Natural products 0.000 claims 4
- 125000003302 alkenyloxy group Chemical group 0.000 claims 4
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 4
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims 4
- 125000005366 cycloalkylthio group Chemical group 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000003884 phenylalkyl group Chemical group 0.000 claims 4
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical group O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000006580 bicyclic heterocycloalkyl group Chemical group 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- BARFJUJHHGUHGZ-DNQXCXABSA-N C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C#C)=O)O Chemical compound C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C#C)=O)O BARFJUJHHGUHGZ-DNQXCXABSA-N 0.000 claims 2
- NQIAOBUVSQRBEP-VSGBNLITSA-N ClC=1C=C2C=CC(=CC2=CC=1)CCC(C(=O)N[C@@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)CN1CCCC1)(F)F Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)CCC(C(=O)N[C@@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)CN1CCCC1)(F)F NQIAOBUVSQRBEP-VSGBNLITSA-N 0.000 claims 2
- VZEKRPWDBJDJSZ-ZJSXRUAMSA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)OC2CC2)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)OC2CC2)CN2CCCC2)=O)C=1 VZEKRPWDBJDJSZ-ZJSXRUAMSA-N 0.000 claims 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 2
- 206010038468 Renal hypertrophy Diseases 0.000 claims 2
- DSZIYURTTGVYOD-ZJSXRUAMSA-N S1C2=C(C=C1C(C(=O)N[C@@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)CN1CCCC1)=O)C=CC=C2 Chemical compound S1C2=C(C=C1C(C(=O)N[C@@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)CN1CCCC1)=O)C=CC=C2 DSZIYURTTGVYOD-ZJSXRUAMSA-N 0.000 claims 2
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- 229910052805 deuterium Inorganic materials 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 201000008627 kidney hypertrophy Diseases 0.000 claims 2
- 230000001537 neural effect Effects 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 208000030761 polycystic kidney disease Diseases 0.000 claims 2
- 238000003786 synthesis reaction Methods 0.000 claims 2
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 claims 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- MCSDYGRIDDNDHG-VRUKGCPNSA-N 2-(5-chloro-1-benzofuran-2-yl)-2,2-dideuterio-N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]acetamide Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)([2H])[2H])C=1 MCSDYGRIDDNDHG-VRUKGCPNSA-N 0.000 claims 1
- QDNHPVQKJZVCKI-KGACXCFTSA-N 2-(5-chloro-1-benzofuran-2-yl)-N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(2,2,5,5-tetradeuteriopyrrolidin-1-yl)propan-2-yl]-2,2-difluoroacetamide Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2C(CCC2([2H])[2H])([2H])[2H])(F)F)C=1 QDNHPVQKJZVCKI-KGACXCFTSA-N 0.000 claims 1
- QDNHPVQKJZVCKI-WZONZLPQSA-N 2-(5-chloro-1-benzofuran-2-yl)-N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2,2-difluoroacetamide Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 QDNHPVQKJZVCKI-WZONZLPQSA-N 0.000 claims 1
- NOQURHLSURANJE-AUSIDOKSSA-N 2-(5-chloro-1-benzofuran-2-yl)-N-[(1R,2R)-1-(6-cyclopropyloxypyridin-3-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-oxoacetamide Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C=2C=NC(=CC=2)OC2CC2)CN2CCCC2)=O)C=1 NOQURHLSURANJE-AUSIDOKSSA-N 0.000 claims 1
- BNTFFRJCZUOBIK-YKSBVNFPSA-N 2-(5-chloro-1-benzofuran-2-yl)-N-[(1S,2R)-1-[3-chloro-4-(2-hydroxy-2-methylpropoxy)phenyl]-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2,2-difluoroacetamide Chemical compound ClC=1C=C(C=CC=1OCC(C)(C)O)[C@@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O BNTFFRJCZUOBIK-YKSBVNFPSA-N 0.000 claims 1
- QDNHPVQKJZVCKI-UDOHKGTISA-N 2-(5-chloro-1-benzofuran-2-yl)-N-[(1S,2R)-1-deuterio-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2,2-difluoroacetamide Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@](O)([2H])C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 QDNHPVQKJZVCKI-UDOHKGTISA-N 0.000 claims 1
- DGRUACDYDOCSJR-ZJSXRUAMSA-N 2-(5-chloro-1-benzothiophen-2-yl)-N-[(1R,2R)-1-(4-cyclopropyloxyphenyl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-oxoacetamide Chemical compound ClC1=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)OC2CC2)CN2CCCC2)=O)C=C1 DGRUACDYDOCSJR-ZJSXRUAMSA-N 0.000 claims 1
- OHKCCUULRFUCTD-JNKRKRSOSA-N 2-(5-chloro-2,3-dihydro-1H-inden-2-yl)-N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2,2-difluoroacetamide Chemical compound ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F OHKCCUULRFUCTD-JNKRKRSOSA-N 0.000 claims 1
- UUIZJYOQYAYVIS-JNKRKRSOSA-N 2-(5-chloro-2,3-dihydro-1H-inden-2-yl)-N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-oxoacetamide Chemical compound ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)=O UUIZJYOQYAYVIS-JNKRKRSOSA-N 0.000 claims 1
- WFOOXDJHXKGNPD-WXEBLKNKSA-N 2-(5-chloro-2,3-dihydro-1H-inden-2-yl)-N-[(1R,2R)-1-(6-cyclopropyloxypyridin-3-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-oxoacetamide Chemical compound ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C=1C=NC(=CC=1)OC1CC1)CN1CCCC1)=O WFOOXDJHXKGNPD-WXEBLKNKSA-N 0.000 claims 1
- QGBSUBCOOMHZCK-GGXMVOPNSA-N 2-[4-(1,3-dimethylindazol-5-yl)phenyl]-N-[(1R,2R)-1-(5-fluoro-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-oxoacetamide Chemical compound CN1N=C(C2=CC(=CC=C12)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O)C QGBSUBCOOMHZCK-GGXMVOPNSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 claims 1
- PZVSDNDODSUBOX-WZONZLPQSA-N BrC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 Chemical compound BrC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 PZVSDNDODSUBOX-WZONZLPQSA-N 0.000 claims 1
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- DNOPTJGAFSUSHT-XRKRLSELSA-N C(C)(C)(C)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound C(C)(C)(C)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O DNOPTJGAFSUSHT-XRKRLSELSA-N 0.000 claims 1
- FBPSOIAWTBNWHH-XRKRLSELSA-N C1(CC1)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound C1(CC1)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O FBPSOIAWTBNWHH-XRKRLSELSA-N 0.000 claims 1
- GMKNBHRFPGFKNV-AOYPEHQESA-N C1(CC1)N1N=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound C1(CC1)N1N=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O GMKNBHRFPGFKNV-AOYPEHQESA-N 0.000 claims 1
- JJLIXUIDEGFQSH-POURPWNDSA-N C1(CC1)N1N=CC2=CC=C(C=C12)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound C1(CC1)N1N=CC2=CC=C(C=C12)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O JJLIXUIDEGFQSH-POURPWNDSA-N 0.000 claims 1
- MCGZPNYXBJJOLH-IXCJQBJRSA-N C1(CC1)OC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O)C(F)(F)F Chemical compound C1(CC1)OC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O)C(F)(F)F MCGZPNYXBJJOLH-IXCJQBJRSA-N 0.000 claims 1
- FJUOAIGYXQOSQR-VSGBNLITSA-N C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O FJUOAIGYXQOSQR-VSGBNLITSA-N 0.000 claims 1
- QOGHZRXNSAWMGQ-CLJLJLNGSA-N C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)N1CCOCC1)=O)O Chemical compound C1(CC1)OC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)N1CCOCC1)=O)O QOGHZRXNSAWMGQ-CLJLJLNGSA-N 0.000 claims 1
- BRUPGTSODWCJBU-LEAFIULHSA-N C1(CC1)OC1=CC=C(C=N1)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=C(C=C2C=C1)F)=O)=O)O Chemical compound C1(CC1)OC1=CC=C(C=N1)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=C(C=C2C=C1)F)=O)=O)O BRUPGTSODWCJBU-LEAFIULHSA-N 0.000 claims 1
- YVNMDIOWYDBFSO-AZZTXQJBSA-N C12N(CC(CC1)C2)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound C12N(CC(CC1)C2)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O YVNMDIOWYDBFSO-AZZTXQJBSA-N 0.000 claims 1
- AAOIORZYPNRDBN-ZJSXRUAMSA-N C1C(CC2=CC=CC=C12)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound C1C(CC2=CC=CC=C12)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F AAOIORZYPNRDBN-ZJSXRUAMSA-N 0.000 claims 1
- LDKIIJASQXZIER-ZJSXRUAMSA-N C1C(CC2=CC=CC=C12)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)=O Chemical compound C1C(CC2=CC=CC=C12)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)=O LDKIIJASQXZIER-ZJSXRUAMSA-N 0.000 claims 1
- OXFAVUXNALHHNE-IXCJQBJRSA-N CC(C)(C)OC1=C(Cl)C=C(C=C1)[C@@H](O)[C@@H](CN1CCCC1)NC(=O)C(=O)C1=CC=C(C=C1)C1=CC=C(F)C=C1 Chemical compound CC(C)(C)OC1=C(Cl)C=C(C=C1)[C@@H](O)[C@@H](CN1CCCC1)NC(=O)C(=O)C1=CC=C(C=C1)C1=CC=C(F)C=C1 OXFAVUXNALHHNE-IXCJQBJRSA-N 0.000 claims 1
- WWMZJNUCLMXYIQ-RCZVLFRGSA-N CC(C)N1C=CC2=C1C=C(C=C2)C(=O)C(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC(F)=C2OCCOC2=C1 Chemical compound CC(C)N1C=CC2=C1C=C(C=C2)C(=O)C(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC(F)=C2OCCOC2=C1 WWMZJNUCLMXYIQ-RCZVLFRGSA-N 0.000 claims 1
- YTLKFLFTKPSUSC-RCZVLFRGSA-N CC(C)N1C=CC2=C1C=CC(=C2)C(=O)C(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC(F)=C2OCCOC2=C1 Chemical compound CC(C)N1C=CC2=C1C=CC(=C2)C(=O)C(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC(F)=C2OCCOC2=C1 YTLKFLFTKPSUSC-RCZVLFRGSA-N 0.000 claims 1
- IFBJSXGXFLOYGZ-GGXMVOPNSA-N CN1N=C(C2=CC=C(C=C12)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O)C Chemical compound CN1N=C(C2=CC=C(C=C12)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O)C IFBJSXGXFLOYGZ-GGXMVOPNSA-N 0.000 claims 1
- YCQKKRBNXUWJEM-XRKRLSELSA-N CN1N=C2C=C(C=CC2=C1C)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound CN1N=C2C=C(C=CC2=C1C)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O YCQKKRBNXUWJEM-XRKRLSELSA-N 0.000 claims 1
- RSKSPZNBNAJZKV-XMSQKQJNSA-N COC1=CC=C(C=C1C(F)F)[C@@H](O)[C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2 Chemical compound COC1=CC=C(C=C1C(F)F)[C@@H](O)[C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2 RSKSPZNBNAJZKV-XMSQKQJNSA-N 0.000 claims 1
- ADAGRSGNGJWVAI-ZCLJVBCSSA-N C[C@@H]1CCCN1C[C@@H](NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)[C@H](O)C1=CC=C2OCCOC2=C1 Chemical compound C[C@@H]1CCCN1C[C@@H](NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)[C@H](O)C1=CC=C2OCCOC2=C1 ADAGRSGNGJWVAI-ZCLJVBCSSA-N 0.000 claims 1
- PFEKZDMCBXYGIV-ATIYNZHBSA-N ClC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O)OCC1(CCOCC1)O Chemical compound ClC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O)OCC1(CCOCC1)O PFEKZDMCBXYGIV-ATIYNZHBSA-N 0.000 claims 1
- TZJVCWRWPIBVAD-UZUQRXQVSA-N ClC1=C(C=CC2=C1C=C(O2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F)Cl Chemical compound ClC1=C(C=CC2=C1C=C(O2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F)Cl TZJVCWRWPIBVAD-UZUQRXQVSA-N 0.000 claims 1
- SFDMHBSWUFMWGY-POURPWNDSA-N ClC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O)O Chemical compound ClC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O)O SFDMHBSWUFMWGY-POURPWNDSA-N 0.000 claims 1
- RHSNKCJVNJYHOI-XMSQKQJNSA-N ClC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O RHSNKCJVNJYHOI-XMSQKQJNSA-N 0.000 claims 1
- BEDXEJOLMHDOBU-XMSQKQJNSA-N ClC1=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=C1 Chemical compound ClC1=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=C1 BEDXEJOLMHDOBU-XMSQKQJNSA-N 0.000 claims 1
- HPWFMXCCAQXFNQ-XMSQKQJNSA-N ClC1=CC2=C(N(C(=N2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C)C=C1 Chemical compound ClC1=CC2=C(N(C(=N2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C)C=C1 HPWFMXCCAQXFNQ-XMSQKQJNSA-N 0.000 claims 1
- PBJSWTAQMSCRKW-FZKQIMNGSA-N ClC1=CC2=C(N=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)S1 Chemical compound ClC1=CC2=C(N=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)S1 PBJSWTAQMSCRKW-FZKQIMNGSA-N 0.000 claims 1
- UQGUSHORHBFUGY-WZONZLPQSA-N ClC1=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=C1 Chemical compound ClC1=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=C1 UQGUSHORHBFUGY-WZONZLPQSA-N 0.000 claims 1
- SBZHZQCQWSEXCE-VGOFRKELSA-N ClC1=CC=2N(C=C1)C=C(N=2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC1=CC=2N(C=C1)C=C(N=2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F SBZHZQCQWSEXCE-VGOFRKELSA-N 0.000 claims 1
- FOGNECSASCDQNZ-DENIHFKCSA-N ClC1=CC=2N(N=C1)C=C(C=2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC1=CC=2N(N=C1)C=C(C=2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F FOGNECSASCDQNZ-DENIHFKCSA-N 0.000 claims 1
- IPNLFXURHFUVKX-SPLOXXLWSA-N ClC1=CC=2OC(=CC=2S1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC1=CC=2OC(=CC=2S1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F IPNLFXURHFUVKX-SPLOXXLWSA-N 0.000 claims 1
- RMPDDXHDMPMLIR-QZRKBOIMSA-N ClC1=CC=C(C=C1)/C=C/C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC1=CC=C(C=C1)/C=C/C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F RMPDDXHDMPMLIR-QZRKBOIMSA-N 0.000 claims 1
- ZYIRIWNEWNKGDP-AOYPEHQESA-N ClC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O ZYIRIWNEWNKGDP-AOYPEHQESA-N 0.000 claims 1
- VHBGFURZYOROIY-SHQCIBLASA-N ClC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)=O Chemical compound ClC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)=O VHBGFURZYOROIY-SHQCIBLASA-N 0.000 claims 1
- PAIZZPWWFVZUPM-HYBUGGRVSA-N ClC1=CC=C(S1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC1=CC=C(S1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O PAIZZPWWFVZUPM-HYBUGGRVSA-N 0.000 claims 1
- VNGZEWPTQASCPY-HOYKHHGWSA-N ClC1=CC=C(S1)C=1SC(=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)F)CN1CCCC1)=O Chemical compound ClC1=CC=C(S1)C=1SC(=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)F)CN1CCCC1)=O VNGZEWPTQASCPY-HOYKHHGWSA-N 0.000 claims 1
- PXLUXEFSQYZNPW-ISKFKSNPSA-N ClC1=CC=C2C=CC(=CC2=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC1=CC=C2C=CC(=CC2=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O PXLUXEFSQYZNPW-ISKFKSNPSA-N 0.000 claims 1
- OOPFCPYNDMJGIN-WZONZLPQSA-N ClC=1C(=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1)Cl Chemical compound ClC=1C(=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1)Cl OOPFCPYNDMJGIN-WZONZLPQSA-N 0.000 claims 1
- YQZHLXIOWYTKMX-XMSQKQJNSA-N ClC=1C=C(C2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1)Cl Chemical compound ClC=1C=C(C2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1)Cl YQZHLXIOWYTKMX-XMSQKQJNSA-N 0.000 claims 1
- KOSLFSKNLYKRLY-HYBUGGRVSA-N ClC=1C=C(C=CC=1OC(C)C)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC(C)C)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O KOSLFSKNLYKRLY-HYBUGGRVSA-N 0.000 claims 1
- NVLCPYWUEVJBIX-DYESRHJHSA-N ClC=1C=C(C=CC=1OC(F)F)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC2=C(S1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC(F)F)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC2=C(S1)C=C(C=C2)Cl)=O)O NVLCPYWUEVJBIX-DYESRHJHSA-N 0.000 claims 1
- QMLXRGBOZVLDHD-YIXXDRMTSA-N ClC=1C=C(C=CC=1OC1CCN(CC1)C)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC1CCN(CC1)C)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O QMLXRGBOZVLDHD-YIXXDRMTSA-N 0.000 claims 1
- MRJNAEINFXYMRL-PQHLKRTFSA-N ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O MRJNAEINFXYMRL-PQHLKRTFSA-N 0.000 claims 1
- HAYXVIAKUQCMOD-IXCJQBJRSA-N ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C1=CC2=CC=C(C=C2C=C1)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C1=CC2=CC=C(C=C2C=C1)Cl)=O)O HAYXVIAKUQCMOD-IXCJQBJRSA-N 0.000 claims 1
- MNEBQZZYVCSIMS-ATIYNZHBSA-N ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC1CCOCC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O MNEBQZZYVCSIMS-ATIYNZHBSA-N 0.000 claims 1
- KFUWZZXWWWWWQO-HYBUGGRVSA-N ClC=1C=C(C=CC=1OC1COC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OC1COC1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O KFUWZZXWWWWWQO-HYBUGGRVSA-N 0.000 claims 1
- XXNOUDBYMXAVQV-XNMGPUDCSA-N ClC=1C=C(C=CC=1OC=C)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound ClC=1C=C(C=CC=1OC=C)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O XXNOUDBYMXAVQV-XNMGPUDCSA-N 0.000 claims 1
- BJZKBXXXLVTICS-IXCJQBJRSA-N ClC=1C=C(C=CC=1OCC(C)(C)O)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound ClC=1C=C(C=CC=1OCC(C)(C)O)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O BJZKBXXXLVTICS-IXCJQBJRSA-N 0.000 claims 1
- PQORAMMKOLQGQX-ATIYNZHBSA-N ClC=1C=C(C=CC=1OCC1(CCOCC1)O)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O Chemical compound ClC=1C=C(C=CC=1OCC1(CCOCC1)O)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O PQORAMMKOLQGQX-ATIYNZHBSA-N 0.000 claims 1
- PPRDULQOZBNTQC-IXCJQBJRSA-N ClC=1C=C(C=CC=1SC1CC1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound ClC=1C=C(C=CC=1SC1CC1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O PPRDULQOZBNTQC-IXCJQBJRSA-N 0.000 claims 1
- LAMYKTIRSGSEGR-ZJSXRUAMSA-N ClC=1C=C(CC(C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)=C)C=CC=1 Chemical compound ClC=1C=C(CC(C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)=C)C=CC=1 LAMYKTIRSGSEGR-ZJSXRUAMSA-N 0.000 claims 1
- PTGAYWXFTOOZPZ-NTKDMRAZSA-N ClC=1C=C2C=C(N(C2=CC=1)C)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC=1C=C2C=C(N(C2=CC=1)C)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F PTGAYWXFTOOZPZ-NTKDMRAZSA-N 0.000 claims 1
- JDHIXKXIWRYDJI-ISKFKSNPSA-N ClC=1C=C2C=CC(=CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O JDHIXKXIWRYDJI-ISKFKSNPSA-N 0.000 claims 1
- OVVOZEPIFJYZMG-RCZVLFRGSA-N ClC=1C=C2C=CC(=CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F OVVOZEPIFJYZMG-RCZVLFRGSA-N 0.000 claims 1
- BQXDVBWQBLVADW-XNMGPUDCSA-N ClC=1C=C2C=CC(=CC2=CC=1)C=1N=C(N(C=1)C)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)C=1N=C(N(C=1)C)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O BQXDVBWQBLVADW-XNMGPUDCSA-N 0.000 claims 1
- RVMYBBAYUIXWJR-XNMGPUDCSA-N ClC=1C=C2C=CC(=CC2=CC=1)N1N=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)N1N=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O RVMYBBAYUIXWJR-XNMGPUDCSA-N 0.000 claims 1
- ZPHLSVFCNDFVMZ-XNMGPUDCSA-N ClC=1C=C2C=CC(=CC2=CC=1)N1N=CC(=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound ClC=1C=C2C=CC(=CC2=CC=1)N1N=CC(=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O ZPHLSVFCNDFVMZ-XNMGPUDCSA-N 0.000 claims 1
- QPNQXRWOZRXFGV-MMCYTVALSA-N ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CCOCC1)Cl)CN1CCCC1)(F)F Chemical compound ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CCOCC1)Cl)CN1CCCC1)(F)F QPNQXRWOZRXFGV-MMCYTVALSA-N 0.000 claims 1
- SVDAVJQRVCUHLX-BMPIVWAPSA-N ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OCC1(CCOCC1)O)Cl)CN1CCCC1)(F)F Chemical compound ClC=1C=C2CC(CC2=CC=1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OCC1(CCOCC1)O)Cl)CN1CCCC1)(F)F SVDAVJQRVCUHLX-BMPIVWAPSA-N 0.000 claims 1
- WCMWNDKYBSJZDD-ZJSXRUAMSA-N ClC=1C=C2CC(CC2=CC=1Cl)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC=1C=C2CC(CC2=CC=1Cl)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F WCMWNDKYBSJZDD-ZJSXRUAMSA-N 0.000 claims 1
- RSKSPZNBNAJZKV-GCJKJVERSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C2=CC(=C(C=C2)OC)C(F)F)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C2=CC(=C(C=C2)OC)C(F)F)CN2CCCC2)(F)F)C=1 RSKSPZNBNAJZKV-GCJKJVERSA-N 0.000 claims 1
- SCJBAGQEVONBFD-DVECYGJZSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(CC2)(C)C)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(CC2)(C)C)(F)F)C=1 SCJBAGQEVONBFD-DVECYGJZSA-N 0.000 claims 1
- LVAYXUOHQGXTBW-WZONZLPQSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C=2OC3=C(C=2)C=C(C=C3)Cl)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@H](O)C=2OC3=C(C=2)C=C(C=C3)Cl)CN2CCCC2)(F)F)C=1 LVAYXUOHQGXTBW-WZONZLPQSA-N 0.000 claims 1
- QDNHPVQKJZVCKI-IZJFFJLRSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@](O)([2H])C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@@](O)([2H])C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 QDNHPVQKJZVCKI-IZJFFJLRSA-N 0.000 claims 1
- BHEWVPQFZPPAHD-XMSQKQJNSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=1 BHEWVPQFZPPAHD-XMSQKQJNSA-N 0.000 claims 1
- PHSQSNLTKGLRLV-WZONZLPQSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)(C)C)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)(C)C)(F)F)C=1 PHSQSNLTKGLRLV-WZONZLPQSA-N 0.000 claims 1
- RNOSLXFQRGEPNC-WZONZLPQSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)C)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)C)(F)F)C=1 RNOSLXFQRGEPNC-WZONZLPQSA-N 0.000 claims 1
- WVYSGOWLBJVBQS-WZONZLPQSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)C)=O)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(C2)C)=O)C=1 WVYSGOWLBJVBQS-WZONZLPQSA-N 0.000 claims 1
- GQHZDFIHSLBMFP-VGOFRKELSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(CC2)(F)F)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC(CC2)(F)F)(F)F)C=1 GQHZDFIHSLBMFP-VGOFRKELSA-N 0.000 claims 1
- LVNWRYLVIJQYHC-NTKDMRAZSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC3(C2)CCC3)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CC3(C2)CCC3)(F)F)C=1 LVNWRYLVIJQYHC-NTKDMRAZSA-N 0.000 claims 1
- FALXMAJSGXLJGP-WZONZLPQSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)=O)C=1 FALXMAJSGXLJGP-WZONZLPQSA-N 0.000 claims 1
- IIOBUFGHYSLATE-YZZKKUAISA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2C[C@H](CC2)F)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2C[C@H](CC2)F)(F)F)C=1 IIOBUFGHYSLATE-YZZKKUAISA-N 0.000 claims 1
- ZNVQZLFIWYVGQU-DYESRHJHSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C=2C=C3C(=NC=2)OCCO3)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C=2C=C3C(=NC=2)OCCO3)CN2CCCC2)(F)F)C=1 ZNVQZLFIWYVGQU-DYESRHJHSA-N 0.000 claims 1
- OYXVPNQHZYLMOP-AUSIDOKSSA-N ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C=2C=NC(=CC=2)OC2CC2)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(C=C(O2)C(C(=O)N[C@@H]([C@H](O)C=2C=NC(=CC=2)OC2CC2)CN2CCCC2)(F)F)C=1 OYXVPNQHZYLMOP-AUSIDOKSSA-N 0.000 claims 1
- FWUMXICMPRLBPA-DYESRHJHSA-N ClC=1C=CC2=C(N=C(S2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 Chemical compound ClC=1C=CC2=C(N=C(S2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C=C2)CN2CCCC2)(F)F)C=1 FWUMXICMPRLBPA-DYESRHJHSA-N 0.000 claims 1
- DSOZFTPDSFGIHH-HYBUGGRVSA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC(=C(C(=C2)OC(C)C)OC)F)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC(=C(C(=C2)OC(C)C)OC)F)CN2CCCC2)=O)C=1 DSOZFTPDSFGIHH-HYBUGGRVSA-N 0.000 claims 1
- MOBJQOSRHVYVFY-HYBUGGRVSA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC(=C(C(=C2)OC)OC(C)C)F)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC(=C(C(=C2)OC)OC(C)C)F)CN2CCCC2)=O)C=1 MOBJQOSRHVYVFY-HYBUGGRVSA-N 0.000 claims 1
- CFGWOYRVFGJHNL-XMSQKQJNSA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC3=C(OCCO3)C(=C2)F)CN2CCCC2)=O)C=1 CFGWOYRVFGJHNL-XMSQKQJNSA-N 0.000 claims 1
- LYJIEEAVDVKLTQ-SHQCIBLASA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)C2=CC=C(C=C2)F)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)C2=CC=C(C=C2)F)CN2CCCC2)=O)C=1 LYJIEEAVDVKLTQ-SHQCIBLASA-N 0.000 claims 1
- PEIBDWLDVCUAFC-WIYYLYMNSA-N ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)Cl)CN2CCCC2)=O)C=1 Chemical compound ClC=1C=CC2=C(SC(=C2)C(C(=O)N[C@@H]([C@H](O)C2=CC=C(C=C2)Cl)CN2CCCC2)=O)C=1 PEIBDWLDVCUAFC-WIYYLYMNSA-N 0.000 claims 1
- ICFVWTFROLYMKL-FZKQIMNGSA-N ClC=1SC2=C(N=1)OC(=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound ClC=1SC2=C(N=1)OC(=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F ICFVWTFROLYMKL-FZKQIMNGSA-N 0.000 claims 1
- FJQDRQVCRASRPO-YIXXDRMTSA-N FC1=C(C=CC=2OCCOC=21)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=C(C=CC=2OCCOC=21)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O FJQDRQVCRASRPO-YIXXDRMTSA-N 0.000 claims 1
- BZCVATAADBANIL-XNMGPUDCSA-N FC1=CC(=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O)C Chemical compound FC1=CC(=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O)C BZCVATAADBANIL-XNMGPUDCSA-N 0.000 claims 1
- IQURZLMHDMSGLW-XNMGPUDCSA-N FC1=CC(=CC2=C1OCC(O2)(C)C)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCC(O2)(C)C)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O IQURZLMHDMSGLW-XNMGPUDCSA-N 0.000 claims 1
- GFKMIHZAWADQBN-XNMGPUDCSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=C(C=C1)C1=CC=C(C=C1)F)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=C(C=C1)C1=CC=C(C=C1)F)C)=O)O GFKMIHZAWADQBN-XNMGPUDCSA-N 0.000 claims 1
- ZYFKZFNKYSISQY-AOYPEHQESA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O)O ZYFKZFNKYSISQY-AOYPEHQESA-N 0.000 claims 1
- VSDZATYMUNEYAM-LEAFIULHSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C2C=NN(C2=C1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C2C=NN(C2=C1)C)=O)O VSDZATYMUNEYAM-LEAFIULHSA-N 0.000 claims 1
- DLSRJYJDRIOIRU-IXCJQBJRSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC2=CN(N=C2C=C1)CC1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC2=CN(N=C2C=C1)CC1=CC=C(C=C1)F)=O)O DLSRJYJDRIOIRU-IXCJQBJRSA-N 0.000 claims 1
- ZENHWDHGGHAYEN-IXCJQBJRSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC2=CN(N=C2C=C1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC2=CN(N=C2C=C1)C)=O)O ZENHWDHGGHAYEN-IXCJQBJRSA-N 0.000 claims 1
- HRPMWBMFXKVUMW-IXCJQBJRSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)(C)O)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)(C)O)=O)O HRPMWBMFXKVUMW-IXCJQBJRSA-N 0.000 claims 1
- NLKMLHDFLNYQEU-XRKRLSELSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)C)=O)O NLKMLHDFLNYQEU-XRKRLSELSA-N 0.000 claims 1
- WUQXPGQIRWRQSS-AOYPEHQESA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O WUQXPGQIRWRQSS-AOYPEHQESA-N 0.000 claims 1
- PWMWUIDUDIPNFO-GRKNLSHJSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C(=NN(C2=C1)C(C)C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C(=NN(C2=C1)C(C)C)C)=O)O PWMWUIDUDIPNFO-GRKNLSHJSA-N 0.000 claims 1
- ZOHUHJUCOKGPEX-GRKNLSHJSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=CN(C2=C1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=CN(C2=C1)C(C)C)=O)O ZOHUHJUCOKGPEX-GRKNLSHJSA-N 0.000 claims 1
- DOWQPIUJJHUTQB-LEAFIULHSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=NN(C2=C1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=NN(C2=C1)C)=O)O DOWQPIUJJHUTQB-LEAFIULHSA-N 0.000 claims 1
- GOVWFJRWRXWXEE-ILBGXUMGSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NC=C(C=C1)F)=O)O GOVWFJRWRXWXEE-ILBGXUMGSA-N 0.000 claims 1
- YTBZPFLSZFUSAL-AOYPEHQESA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NN(C=C1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NN(C=C1)C(C)C)=O)O YTBZPFLSZFUSAL-AOYPEHQESA-N 0.000 claims 1
- ZBXQPTCLLVMHEJ-GRKNLSHJSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=CN(C2=CC=1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=CN(C2=CC=1)C(C)C)=O)O ZBXQPTCLLVMHEJ-GRKNLSHJSA-N 0.000 claims 1
- DCCROHWSSRPMIC-LEAFIULHSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O)O DCCROHWSSRPMIC-LEAFIULHSA-N 0.000 claims 1
- LNTGNHJLWBAMIP-BVRKHOPBSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=CC2=C(N(N=C2C=1)C(C)C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=CC2=C(N(N=C2C=1)C(C)C)C)=O)O LNTGNHJLWBAMIP-BVRKHOPBSA-N 0.000 claims 1
- OHGQSFCJPNSHKP-AOYPEHQESA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=NN(C=1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=NN(C=1)C(C)C)=O)O OHGQSFCJPNSHKP-AOYPEHQESA-N 0.000 claims 1
- GCFFKFZMZWRNKF-ZJSXRUAMSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C2C=NN(C2=C1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C2C=NN(C2=C1)C(C)C)=O)O GCFFKFZMZWRNKF-ZJSXRUAMSA-N 0.000 claims 1
- CMKXUSJVCIOYDD-DENIHFKCSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C2C=NN(C2=C1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C2C=NN(C2=C1)C)=O)O CMKXUSJVCIOYDD-DENIHFKCSA-N 0.000 claims 1
- KUTHEDNGHPJFJA-AOYPEHQESA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C(C=CC=1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C(C=CC=1)C1=CC=C(C=C1)F)=O)O KUTHEDNGHPJFJA-AOYPEHQESA-N 0.000 claims 1
- XVHVFJMEYDXYST-DENIHFKCSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)C)=O)O XVHVFJMEYDXYST-DENIHFKCSA-N 0.000 claims 1
- MXIVDAKDLMNPDD-LEAFIULHSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)CC1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)CC1=CC=C(C=C1)F)=O)O MXIVDAKDLMNPDD-LEAFIULHSA-N 0.000 claims 1
- QERFQFNOULNJNK-ISKFKSNPSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=CC2=CN(N=C2C=1)C(C)C)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=CC2=CN(N=C2C=1)C(C)C)=O)O QERFQFNOULNJNK-ISKFKSNPSA-N 0.000 claims 1
- AUVKWWLAXWRBSE-FYYLOGMGSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=NN(C=1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=NN(C=1)C1=CC=C(C=C1)F)=O)O AUVKWWLAXWRBSE-FYYLOGMGSA-N 0.000 claims 1
- OONUMYJAXKCVOD-DENIHFKCSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=C(SC=1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=C(SC=1)C1=CC=C(C=C1)F)=O)O OONUMYJAXKCVOD-DENIHFKCSA-N 0.000 claims 1
- YUMQBZOEOAPHJB-FYYLOGMGSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=CN(C=1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=CN(C=1)C1=CC=C(C=C1)F)=O)O YUMQBZOEOAPHJB-FYYLOGMGSA-N 0.000 claims 1
- ZFDPIMHIGYOMEF-HYBUGGRVSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1SC(=CC=1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1SC(=CC=1)C1=CC=C(C=C1)F)=O)O ZFDPIMHIGYOMEF-HYBUGGRVSA-N 0.000 claims 1
- QCDHUEHELHXYNE-ISKFKSNPSA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)N1CCN(CC1)C1=CC=C(C=C1)F)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)N1CCN(CC1)C1=CC=C(C=C1)F)=O)O QCDHUEHELHXYNE-ISKFKSNPSA-N 0.000 claims 1
- XOCONAFXKBBMRR-SHQCIBLASA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=C(C=C2C=C1)F)=O)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=C(C=C2C=C1)F)=O)=O)O XOCONAFXKBBMRR-SHQCIBLASA-N 0.000 claims 1
- WTEGDYORFDWRSA-SHQCIBLASA-N FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=CC=C2C=C1)=O)=O)O Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=CC=C2C=C1)=O)=O)O WTEGDYORFDWRSA-SHQCIBLASA-N 0.000 claims 1
- LAFQWFROWPCTIJ-AOYPEHQESA-N FC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@@H](C1=CC2=C(OCCO2)C(=C1)C(F)(F)F)O)CN1CCCC1)=O Chemical compound FC1=CC=C(C=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@@H](C1=CC2=C(OCCO2)C(=C1)C(F)(F)F)O)CN1CCCC1)=O LAFQWFROWPCTIJ-AOYPEHQESA-N 0.000 claims 1
- RDLVNJBVFPSQBS-IXCJQBJRSA-N FC=1C=C(C=C(C=1OC(C)C)OC)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound FC=1C=C(C=C(C=1OC(C)C)OC)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O RDLVNJBVFPSQBS-IXCJQBJRSA-N 0.000 claims 1
- 208000024720 Fabry Disease Diseases 0.000 claims 1
- 201000008892 GM1 Gangliosidosis Diseases 0.000 claims 1
- 208000015872 Gaucher disease Diseases 0.000 claims 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 claims 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- YAQKKEXFQQGWBY-UFHPHHKVSA-N N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-4-(6-fluoronaphthalen-2-yl)-2-oxobutanamide Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(CCC1=CC2=CC=C(C=C2C=C1)F)=O)=O)O YAQKKEXFQQGWBY-UFHPHHKVSA-N 0.000 claims 1
- IRQOOQNBUOZZSA-JWQCQUIFSA-N N-[(1R,2R)-1-(4-chlorophenyl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-[4-(4-fluorophenyl)phenyl]-2-oxoacetamide Chemical compound ClC1=CC=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O IRQOOQNBUOZZSA-JWQCQUIFSA-N 0.000 claims 1
- YMCNCESCSZYJJN-AOYPEHQESA-N N-[(1R,2R)-1-(5-chloro-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-[4-(4-fluorophenyl)phenyl]-2-oxoacetamide Chemical compound ClC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O YMCNCESCSZYJJN-AOYPEHQESA-N 0.000 claims 1
- PUSCVWIVTPPCRJ-FYYLOGMGSA-N N-[(1R,2R)-1-(5-fluoro-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-[4-(4-fluorophenyl)-1-methylimidazol-2-yl]-2-oxoacetamide Chemical compound FC1=CC(=CC2=C1OCCO2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N(C=C(N=1)C1=CC=C(C=C1)F)C)=O)O PUSCVWIVTPPCRJ-FYYLOGMGSA-N 0.000 claims 1
- OWBFPPPJFQJBOX-WZONZLPQSA-N N-[(1R,2R)-1-(6-bromo-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]-2-(5-chloro-1-benzofuran-2-yl)-2,2-difluoroacetamide Chemical compound O[C@@H]([C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)C1=C(Br)C=C2OCCOC2=C1 OWBFPPPJFQJBOX-WZONZLPQSA-N 0.000 claims 1
- DHQSWJMSSOQLMW-FHDOQAETSA-N N-[(1R,2R)-3-(7-azabicyclo[2.2.1]heptan-7-yl)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxypropan-2-yl]-2-(5-chloro-1-benzofuran-2-yl)-2,2-difluoroacetamide Chemical compound C12CCC(CC1)N2C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O DHQSWJMSSOQLMW-FHDOQAETSA-N 0.000 claims 1
- DLNXZCCQJPOMDF-DYESRHJHSA-N N-[(1R,2R)-3-(azetidin-1-yl)-1-(5-fluoro-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxypropan-2-yl]-2-(5-chloro-1-benzofuran-2-yl)-2-oxoacetamide Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C=1OC2=C(C=1)C=C(C=C2)Cl)=O DLNXZCCQJPOMDF-DYESRHJHSA-N 0.000 claims 1
- DZNFWSDYRYAUDD-SXHSKPAUSA-N N-[(1R,2R)-3-(azetidin-1-yl)-1-(5-fluoro-2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxypropan-2-yl]-2-(5-chloro-2,3-dihydro-1H-inden-2-yl)-2,2-difluoroacetamide Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(F)(F)C1CC2=CC=C(C=C2C1)Cl)=O DZNFWSDYRYAUDD-SXHSKPAUSA-N 0.000 claims 1
- DRPBDADWNZZEEB-ATIYNZHBSA-N N1(CCC1)CCOC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O)Cl Chemical compound N1(CCC1)CCOC1=C(C=C(C=C1)[C@H]([C@@H](CN1CCCC1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O)O)Cl DRPBDADWNZZEEB-ATIYNZHBSA-N 0.000 claims 1
- OWQRNSHYKZDPSN-VGSWGCGISA-N N1(CCC1)C[C@H]([C@@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound N1(CCC1)C[C@H]([C@@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O OWQRNSHYKZDPSN-VGSWGCGISA-N 0.000 claims 1
- LPHMKOLAISWCTD-ILBGXUMGSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)Cl)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)Cl)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O LPHMKOLAISWCTD-ILBGXUMGSA-N 0.000 claims 1
- BORYQDATHVMEDC-GGXMVOPNSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)Cl)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)Cl)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O BORYQDATHVMEDC-GGXMVOPNSA-N 0.000 claims 1
- GNSWMPOWXMVVMY-ILBGXUMGSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O GNSWMPOWXMVVMY-ILBGXUMGSA-N 0.000 claims 1
- GOZLSEHRKIWPOO-FYYLOGMGSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC2=CC=C(C=C2C=C1)Cl)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC2=CC=C(C=C2C=C1)Cl)=O GOZLSEHRKIWPOO-FYYLOGMGSA-N 0.000 claims 1
- HUICGEXPSWKTFM-IXCJQBJRSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)(C)C)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C(C)(C)C)=O HUICGEXPSWKTFM-IXCJQBJRSA-N 0.000 claims 1
- SDKVKDMCRWYERW-ILBGXUMGSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O SDKVKDMCRWYERW-ILBGXUMGSA-N 0.000 claims 1
- FYSGUNXOOPFPNY-GGXMVOPNSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=NN(C2=C1)C1CC1)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C1=CC=C2C=NN(C2=C1)C1CC1)=O FYSGUNXOOPFPNY-GGXMVOPNSA-N 0.000 claims 1
- PUBZDUPNXLFJLB-SHQCIBLASA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O PUBZDUPNXLFJLB-SHQCIBLASA-N 0.000 claims 1
- ZVYQWOCZBLVAEF-GGXMVOPNSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C1CC1)=O ZVYQWOCZBLVAEF-GGXMVOPNSA-N 0.000 claims 1
- HIJCNZUGWVZWIE-ZEQKJWHPSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(CCC1=CC2=CC=CC=C2C=C1)=O)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(CCC1=CC2=CC=CC=C2C=C1)=O)=O HIJCNZUGWVZWIE-ZEQKJWHPSA-N 0.000 claims 1
- PVQIWXOLDXEPIH-DYESRHJHSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O PVQIWXOLDXEPIH-DYESRHJHSA-N 0.000 claims 1
- RIUSNWVLFBFUCH-VGOFRKELSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(=O)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(=O)C=1OC2=C(C=1)C=C(C=C2)Cl)=O RIUSNWVLFBFUCH-VGOFRKELSA-N 0.000 claims 1
- OWQRNSHYKZDPSN-VGOFRKELSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O OWQRNSHYKZDPSN-VGOFRKELSA-N 0.000 claims 1
- WPBIMINVUZTVGR-KAYWLYCHSA-N N1(CCC1)C[C@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O Chemical compound N1(CCC1)C[C@H]([C@H](O)C1=CC=C(C=C1)OC1CC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O WPBIMINVUZTVGR-KAYWLYCHSA-N 0.000 claims 1
- QMJXRVYZZSVSBW-ILBGXUMGSA-N N1(N=CC=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)Cl)CN1CCCC1)=O Chemical compound N1(N=CC=C1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)Cl)CN1CCCC1)=O QMJXRVYZZSVSBW-ILBGXUMGSA-N 0.000 claims 1
- BOGIKQOQJFUDLN-ZEQKJWHPSA-N N1=CC=NC=2C=C3C(=CC1=2)CC(C3)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound N1=CC=NC=2C=C3C(=CC1=2)CC(C3)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F BOGIKQOQJFUDLN-ZEQKJWHPSA-N 0.000 claims 1
- ICEASJMOQCCCEH-ISKFKSNPSA-N N=1N(N=CC=1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)Cl)CN1CCCC1)=O Chemical compound N=1N(N=CC=1)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC(=C(C=C1)OC1CC1)Cl)CN1CCCC1)=O ICEASJMOQCCCEH-ISKFKSNPSA-N 0.000 claims 1
- VVCSGDNPRWZFCB-LLUPJZLQSA-N NC1CC2CCC(C1)N2C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O Chemical compound NC1CC2CCC(C1)N2C[C@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)NC(C(F)(F)C=1OC2=C(C=1)C=C(C=C2)Cl)=O VVCSGDNPRWZFCB-LLUPJZLQSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- LYXKFUXXLTXQDI-WZONZLPQSA-N O1C(=CC2=C1C=CC=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound O1C(=CC2=C1C=CC=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F LYXKFUXXLTXQDI-WZONZLPQSA-N 0.000 claims 1
- BEIFOAXFXNTHJG-WZONZLPQSA-N O1C2=C(OCC1)C=C(C=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F Chemical compound O1C2=C(OCC1)C=C(C=C2)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C=C1)CN1CCCC1)(F)F BEIFOAXFXNTHJG-WZONZLPQSA-N 0.000 claims 1
- GTLPYBCDIAJUKV-YIXXDRMTSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1C(CCC1)=O)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1C(CCC1)=O)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O GTLPYBCDIAJUKV-YIXXDRMTSA-N 0.000 claims 1
- OEHWFVBDZQDUTN-SHQCIBLASA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC(=CC=C1)OC1=CC=C(C=C1)F)=O)O OEHWFVBDZQDUTN-SHQCIBLASA-N 0.000 claims 1
- XVJNSLWBFQWQNG-ZEQKJWHPSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=NC=C(C=C1)F)=O)O XVJNSLWBFQWQNG-ZEQKJWHPSA-N 0.000 claims 1
- OWOJDYPHFYISNC-VAVYLYDRSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C1=CC=C(C=C1)C=1C=C2C=NN(C2=CC=1)C)=O)O OWOJDYPHFYISNC-VAVYLYDRSA-N 0.000 claims 1
- LANCXYDDSSDCEV-AUSIDOKSSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)C)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1C=C2C=NN(C2=CC=1)C)=O)O LANCXYDDSSDCEV-AUSIDOKSSA-N 0.000 claims 1
- WZJXXVBQJOXROQ-AUSIDOKSSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=C(SC=1)C1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1N=C(SC=1)C1=CC=C(C=C1)F)=O)O WZJXXVBQJOXROQ-AUSIDOKSSA-N 0.000 claims 1
- BNIQDLUVINYBQD-CJFMBICVSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1SC(=CC=1)C1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)C=1SC(=CC=1)C1=CC=C(C=C1)F)=O)O BNIQDLUVINYBQD-CJFMBICVSA-N 0.000 claims 1
- RKVZUMAIVNBVJC-RCZVLFRGSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)N1CCN(CC1)C1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H](CN1CCCC1)NC(C(=O)N1CCN(CC1)C1=CC=C(C=C1)F)=O)O RKVZUMAIVNBVJC-RCZVLFRGSA-N 0.000 claims 1
- TWJGXXRHSSOIRY-DTHMXLAUSA-N O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H]([C@H](C)N1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O Chemical compound O1C2=C(OCC1)C=C(C=C2)[C@H]([C@@H]([C@H](C)N1CCCC1)NC(C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)=O)O TWJGXXRHSSOIRY-DTHMXLAUSA-N 0.000 claims 1
- PXWIZXHAUWCYBE-SHQCIBLASA-N O1N=CC2=C1C=C(C=C2)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound O1N=CC2=C1C=C(C=C2)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O PXWIZXHAUWCYBE-SHQCIBLASA-N 0.000 claims 1
- PBPDXLAPKHLBHA-SHQCIBLASA-N O1N=CC2=C1C=CC(=C2)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O Chemical compound O1N=CC2=C1C=CC(=C2)C1=CC=C(C=C1)C(C(=O)N[C@@H]([C@H](O)C1=CC2=C(OCCO2)C(=C1)F)CN1CCCC1)=O PBPDXLAPKHLBHA-SHQCIBLASA-N 0.000 claims 1
- PWXWZVPCCKAIGV-ZMFCXZKHSA-N O[C@@H]([C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)C1=CC(Cl)=C(OC2CCOC2)C=C1 Chemical compound O[C@@H]([C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)C1=CC(Cl)=C(OC2CCOC2)C=C1 PWXWZVPCCKAIGV-ZMFCXZKHSA-N 0.000 claims 1
- LVAYXUOHQGXTBW-JPYJTQIMSA-N O[C@@H]([C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)C1=CC2=C(O1)C=CC(Cl)=C2 Chemical compound O[C@@H]([C@@H](CN1CCCC1)NC(=O)C(F)(F)C1=CC2=C(O1)C=CC(Cl)=C2)C1=CC2=C(O1)C=CC(Cl)=C2 LVAYXUOHQGXTBW-JPYJTQIMSA-N 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000021811 Sandhoff disease Diseases 0.000 claims 1
- 208000022292 Tay-Sachs disease Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 150000002305 glucosylceramides Chemical class 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 claims 1
- 201000008980 hyperinsulinism Diseases 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 0 *C(*)(*)C(CN(*)*)N(*)* Chemical compound *C(*)(*)C(CN(*)*)N(*)* 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361880752P | 2013-09-20 | 2013-09-20 | |
| US61/880,752 | 2013-09-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515409A Division JP6537500B2 (ja) | 2013-09-20 | 2014-09-19 | 疾患治療用のグルコシルセラミドシンターゼ阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019182869A JP2019182869A (ja) | 2019-10-24 |
| JP2019182869A5 true JP2019182869A5 (cg-RX-API-DMAC10.html) | 2020-01-16 |
Family
ID=51794951
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515409A Active JP6537500B2 (ja) | 2013-09-20 | 2014-09-19 | 疾患治療用のグルコシルセラミドシンターゼ阻害剤 |
| JP2019104161A Pending JP2019182869A (ja) | 2013-09-20 | 2019-06-04 | 疾患治療用のグルコシルセラミドシンターゼ阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515409A Active JP6537500B2 (ja) | 2013-09-20 | 2014-09-19 | 疾患治療用のグルコシルセラミドシンターゼ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10227323B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP3912977A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP6537500B2 (cg-RX-API-DMAC10.html) |
| CN (2) | CN110372636B (cg-RX-API-DMAC10.html) |
| AU (2) | AU2014321397C1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2924545C (cg-RX-API-DMAC10.html) |
| IL (2) | IL244628B (cg-RX-API-DMAC10.html) |
| MX (1) | MX374452B (cg-RX-API-DMAC10.html) |
| TW (2) | TWI690511B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2015042397A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110372636B (zh) | 2013-09-20 | 2023-03-28 | 生物马林药物股份有限公司 | 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂 |
| US11744396B1 (en) * | 2015-11-10 | 2023-09-05 | Caffeine Innovations, LLC | System, method, and device for agitating coffee grounds |
| CN105541819B (zh) * | 2016-02-04 | 2018-09-14 | 浙江永宁药业股份有限公司 | 一种依匹唑派的制备方法及其中间体和中间体的制备方法 |
| CN107216238A (zh) * | 2016-03-21 | 2017-09-29 | 湖南师范大学 | 醇镁法制备4-甲基儿茶酚 |
| WO2018041935A1 (en) * | 2016-09-02 | 2018-03-08 | Igm Group B.V. | Polycyclic glyoxylates as photoinitiators |
| WO2018118838A1 (en) * | 2016-12-20 | 2018-06-28 | Biomarin Pharmaceutical Inc. | Ceramide galactosyltransferase inhibitors for the treatment of disease |
| AR111295A1 (es) | 2017-03-20 | 2019-06-26 | Forma Therapeutics Inc | Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr) |
| WO2018177781A1 (en) | 2017-03-28 | 2018-10-04 | Basf Se | Pesticidal compounds |
| US11512054B2 (en) | 2017-12-21 | 2022-11-29 | Basf Se | Pesticidal compounds |
| US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| WO2020061255A1 (en) | 2018-09-19 | 2020-03-26 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| CN111393405B (zh) * | 2019-01-02 | 2022-11-25 | 中国科学院上海药物研究所 | 一类含氟取代的苯并噻吩类化合物及其药物组合物及应用 |
| EP3993878A4 (en) * | 2019-07-01 | 2023-11-08 | Curasen Therapeutics, Inc. | BETA-ADRENERGIC AGONIST AND RELATED METHODS OF USE |
| WO2021020363A1 (ja) * | 2019-07-29 | 2021-02-04 | 武田薬品工業株式会社 | 複素環化合物 |
| MX2022003025A (es) | 2019-09-19 | 2022-04-07 | Forma Therapeutics Inc | Activacion de la piruvato cinasa r. |
| US11220479B2 (en) * | 2019-10-23 | 2022-01-11 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| US12338237B2 (en) | 2019-11-15 | 2025-06-24 | Yuhan Corporation | Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the same |
| ES3058346T3 (es) | 2019-11-15 | 2026-03-10 | Yuhan Corp | Derivados que tienen un resto 2,3-dihidro-1H-indeno o 2,3-dihidrobenzofurano o una sal farmacéuticamente aceptable de mismo y composiciones farmacéuticas que comprenden los mismos |
| WO2021221953A1 (en) | 2020-04-28 | 2021-11-04 | The Regents Of The University Of Michigan | Pyridine inhibitors of glucosylceramide synthase and therapeutic methods using the same |
| CN114621140B (zh) * | 2020-12-10 | 2023-08-11 | 中国科学院上海药物研究所 | 芳基二氟乙酰胺化合物及其制备方法和用途 |
| CN112457277B (zh) * | 2020-12-16 | 2022-06-28 | 西安国康瑞金制药有限公司 | 一种他氟前列腺素的制备方法 |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
| CN113912544B (zh) * | 2021-11-29 | 2023-03-17 | 沧州普瑞东方科技有限公司 | 一种5-溴-1-甲基吲唑的制备方法 |
| AU2023284213A1 (en) * | 2022-06-10 | 2024-10-31 | Ishihara Sangyo Kaisha, Ltd. | Herbicidal composition containing difluorobutenoic acid amide compound |
| WO2024037422A1 (en) * | 2022-08-18 | 2024-02-22 | Acelink Therapeutics (Suzhou) Co., Ltd | Crystalline forms of a glucosylceramide synthase inhibitor and uses thereof |
| CN115433157B (zh) * | 2022-11-09 | 2023-02-07 | 苏州凯瑞医药科技有限公司 | 一种依利格鲁司特中间体的制备方法 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756528A (en) | 1995-06-06 | 1998-05-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| NO965193L (no) | 1995-12-08 | 1997-06-09 | Seikagaku Kogyo Kk Seikagaku C | Aminalkoholderivat og fremgangsmåte for fremstilling derav |
| JP4036500B2 (ja) | 1997-05-23 | 2008-01-23 | 生化学工業株式会社 | アミノアルコール誘導体及びそれを含有する医薬 |
| JP4176170B2 (ja) | 1997-06-06 | 2008-11-05 | 生化学工業株式会社 | アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬 |
| US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| RU2263109C2 (ru) | 1999-05-07 | 2005-10-27 | Тексэс Байотекнолоджи Копэрейшн | ПРОИЗВОДНЫЕ КАРБОНОВЫХ КИСЛОТ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ СЕЛЕКТИВНОГО ИНГИБИРОВАНИЯ СВЯЗЫВАНИЯ α4β1 ИНТЕГРИНА У МЛЕКОПИТАЮЩЕГО |
| US6407064B2 (en) | 1999-12-06 | 2002-06-18 | Seikagaku Corporation | Aminoalcohol derivative and medicament comprising the same |
| WO2002080920A1 (en) | 2001-04-06 | 2002-10-17 | Axys Pharmaceuticals, Inc. | Arylacetamido-ketobenzoxazole as cysteine protease inhibitors |
| US6855830B2 (en) | 2001-07-16 | 2005-02-15 | Genzyme Corporation | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| WO2003045928A1 (en) | 2001-11-26 | 2003-06-05 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| AU2002367266A1 (en) | 2001-12-28 | 2003-07-24 | Sumitomo Pharmaceuticals Company, Limited | Disease markers for renal diseaes and utilization thereof |
| CA2518171C (en) | 2003-03-06 | 2013-07-09 | Neose Technologies, Inc. | Methods and compositions for the enzymatic synthesis of gangliosides |
| GB0400812D0 (en) | 2004-01-14 | 2004-02-18 | Celltech R&D Ltd | Novel compounds |
| JP4242911B2 (ja) * | 2004-08-26 | 2009-03-25 | ファイザー・インク | プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリール化合物 |
| BRPI0517701A8 (pt) * | 2004-11-10 | 2018-01-23 | Genzyme Corp | métodos de tratamento de diabetes mellitus |
| PL383715A1 (pl) | 2005-01-26 | 2008-05-12 | Allergan, Inc. | Amidy kwasu 3-arylo-3-hydroksy-2-amino-propionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-amino-propionowego i ich związki pokrewne posiadające aktywność przeciwbólową i/lub pobudzającą odporność |
| ES2546181T3 (es) | 2006-05-09 | 2015-09-21 | Genzyme Corporation | Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos |
| WO2008011487A2 (en) | 2006-07-19 | 2008-01-24 | Allergan, Inc. | L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain |
| WO2008011483A2 (en) | 2006-07-19 | 2008-01-24 | Allergan, Inc. | Methods for treating chronic pain using 1- (hetero) aryl-1-hydroxy 2,3-diamino-propyl amines and related compounds |
| GB0614947D0 (en) | 2006-07-27 | 2006-09-06 | Isis Innovation | Epitope reduction therapy |
| WO2008109286A1 (en) | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| EP2594565B1 (en) * | 2007-05-31 | 2018-10-24 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| US7897619B2 (en) | 2007-07-17 | 2011-03-01 | Amgen Inc. | Heterocyclic modulators of PKB |
| KR101640263B1 (ko) | 2007-10-05 | 2016-07-15 | 젠자임 코포레이션 | 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법 |
| AR070950A1 (es) | 2007-11-01 | 2010-05-19 | Acucela Inc | Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos |
| CN101998959B (zh) * | 2008-02-06 | 2013-08-28 | 生物马林药物股份有限公司 | 聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂 |
| WO2009117150A2 (en) | 2008-03-20 | 2009-09-24 | Genzyme Corporation | Method of treating lupus with ceramide derivatives |
| JP2011529500A (ja) | 2008-07-28 | 2011-12-08 | ジェンザイム コーポレーション | 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害 |
| GB0817576D0 (en) | 2008-09-25 | 2008-11-05 | Lectus Therapeutics Ltd | Calcium ion channel modulators & uses thereof |
| CN102271678B (zh) | 2008-10-03 | 2017-06-30 | 简詹姆公司 | 2‑酰胺基丙醇型葡糖神经酰胺合成酶抑制剂 |
| MY192644A (en) * | 2009-11-27 | 2022-08-29 | Genzyme Corp | An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
| US20110144081A1 (en) * | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
| US8961959B2 (en) * | 2011-10-17 | 2015-02-24 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| WO2014150043A1 (en) * | 2013-03-15 | 2014-09-25 | Concert Pharmaceuticals Inc. | Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase |
| CN110372636B (zh) * | 2013-09-20 | 2023-03-28 | 生物马林药物股份有限公司 | 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂 |
-
2014
- 2014-09-19 CN CN201910659073.4A patent/CN110372636B/zh active Active
- 2014-09-19 TW TW103132529A patent/TWI690511B/zh active
- 2014-09-19 WO PCT/US2014/056555 patent/WO2015042397A1/en not_active Ceased
- 2014-09-19 EP EP21177756.0A patent/EP3912977A1/en active Pending
- 2014-09-19 US US15/023,337 patent/US10227323B2/en active Active
- 2014-09-19 CA CA2924545A patent/CA2924545C/en active Active
- 2014-09-19 EP EP14789439.8A patent/EP3046920B1/en active Active
- 2014-09-19 AU AU2014321397A patent/AU2014321397C1/en active Active
- 2014-09-19 CN CN201480063521.XA patent/CN105745206B/zh active Active
- 2014-09-19 TW TW108108615A patent/TW201945337A/zh unknown
- 2014-09-19 JP JP2016515409A patent/JP6537500B2/ja active Active
- 2014-09-19 MX MX2016003486A patent/MX374452B/es active IP Right Grant
-
2016
- 2016-03-16 IL IL244628A patent/IL244628B/en active IP Right Grant
-
2019
- 2019-01-31 US US16/264,505 patent/US10927092B2/en active Active
- 2019-05-06 AU AU2019203155A patent/AU2019203155A1/en not_active Abandoned
- 2019-06-04 JP JP2019104161A patent/JP2019182869A/ja active Pending
- 2019-07-29 IL IL268340A patent/IL268340A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016534023A5 (cg-RX-API-DMAC10.html) | ||
| TWI567068B (zh) | Ｔｒｋ抑制化合物 | |
| US8492582B2 (en) | N-acyl anthranilic acid derivative or salt thereof | |
| JP2021169499A (ja) | ヒト血漿カリクレイン阻害剤 | |
| US20210338653A1 (en) | N-[2-(1 -benzylpiperidin-4-yl)ethyl]-4-(pyrazin-2-yl)-piperazine-1 -carboxamide derivatives and related compounds as muscarinic receptor 4 (m4) antagonists for treating neurological diseases | |
| BG108013A (bg) | Заместени аминопроизводни и методи за използването им | |
| JP2021533093A (ja) | モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物 | |
| JP4685068B2 (ja) | 脈管形成阻害活性を有するアリール尿素 | |
| AU2006239418A1 (en) | Novel oxadiazole derivatives and their medical use | |
| EP3083611B1 (en) | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases | |
| KR20170094263A (ko) | Ｎａｄｐｈ 옥시다제 억제제인 아미도 티아디아졸 유도체 | |
| JP7744350B2 (ja) | 置換ピラゾロ－ピリミジンおよびその使用 | |
| JPWO2002088107A1 (ja) | ピラゾリル基を置換基として有する含窒素縮合環化合物およびその医薬組成物 | |
| MX2014013011A (es) | Compuesto heterociclico nitrogenado. | |
| JP2011530483A (ja) | アミド化合物 | |
| KR20050004214A (ko) | 피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물 | |
| CN115989228A (zh) | 杂环化合物 | |
| JP2009538358A (ja) | 脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター | |
| EA022012B1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРАЗИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ, ПСИХИАТРИЧЕСКИХ И МЕТАБОЛИЧЕСКИХ РАССТРОЙСТВ И ЗАБОЛЕВАНИЙ | |
| JP2019163256A (ja) | イミダゾピリダジン化合物 | |
| KR20140041609A (ko) | 선택적 프로테인 키나제 저해제로서 옥사졸 및 티아졸 유도체 | |
| US20190345165A1 (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
| US20240299385A1 (en) | 3-pyrrolylsulfonamide compounds as gpr17 antagonists | |
| JP2008543781A (ja) | ホスフオジエステラーゼ４阻害剤 | |
| US11731943B2 (en) | Therapeutic compounds, compositions and methods of use thereof |